Replies to post #825 on Safeplus International Holdings Ltd. (ACAI)

[Buffalobill91]

here is a post from RB to shed some light on what you are talking about... Looks like MW has all the bases covered

.....

re Biotronik's AMS
Biotronik's Absorbable Metal Stent (AMS) appears that it might be a breakthrough in stent technology.

The technology for their AMS has been collaborated on heavily by Aachen Resonance, from whom Biophan recently acquired exclusive rights to advanced mri technology for coated stents. Biotronik's AMS is being developed in Europe to eventually be marketed as a coated, drug-eluting stent (DES). Aachen's CEO, Dr. Alexander Reubben and Dr. Bucker, Aachen's renowned mri expert, are now under contract with BIPH to further develop the technology that they licensed to BIPH. At the same time, they are working closely with Biotronik on the drug-eluting AMS.

Something tells me that BIPH has a finger in Biotronik's future AMS pie.

Biotronik/Aachen collaboration link:
http://www.biotronik.com/content/detail.php?id=2685

Biophan / Aachen licensing deal p/r link:
http://www.biophan.com/pr/061605License.html